Comparison

Apricitabine European Partner

Item no. TMO-T14313-50mg
Manufacturer TargetMol
CASRN 160707-69-7
Amount 50 mg
Quantity options 100 mg 10 mg 1 mL 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles O=C1N([C@@H]2S[C@H](CO)OC2)C=CC(N)=N1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias SPD754, AVX754
Shipping condition Cool pack
Available
Manufacturer - Targets
HIV Protease|||DNA/RNA Synthesis
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
229, 26
Target names or alias
AVX754 , SPD754
Description
Apricitabine (SPD754) is a highly selective and orally active HIV-1 reverse transcriptase inhibitor (Ki=0.08 μM), the (-) enantiomer of 2′-deoxy-3′-oxy-4′-thiocytidine (dOTC) . Apricitabine inhibits DNA polymerase α, β and γ with Ki values of 300 μM, 12 μM and 112.25 μM, respectively. Apricitabine has shown good antiretroviral therapeutic efficacy in antiretroviral HIV-infected patients, with good tolerability and low selective resistance.
Pathways
Proteases/Proteasome|||Cell Cycle/Checkpoint|||DNA Damage/DNA Repair|||Microbiology/Virology

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close